Company intelligence
Dxcover
The Future of Cancer Diagnostics
Medical Equipment Manufacturing
11–50 employees
Founded 2016
1 public signals
About Dxcover
Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating pan-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA.
Verified activity
Signals from Dxcover
1 published signal